CRBU FY 2022 Earnings — Caribou Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CRBUCaribou Biosciences, Inc.

$186M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14M+44.3% YoY

Gross Profit

$10M73.7% margin

Operating Income

-$106M-768.2% margin

Net Income

-$99M-717.8% margin

EPS (Diluted)

$-1.64

Cash Flow

Operating Cash Flow

-$91M

Free Cash Flow

-$97M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$374M

Total Liabilities

$73M

Stockholders' Equity

$301M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$10M	+44.3%
Gross Profit	$10M	$9M	+18.5%
Operating Income	-$106M	-$67M	-58.9%
Net Income	-$99M	-$67M	-48.6%